Mountain Lake Acquisition II (MLAA)
Market Price (5/30/2026): $9.92 | Market Cap: $366.9 MilSector: Financials | Industry: Multi-Sector Holdings
Mountain Lake Acquisition II (MLAA)
Market Price (5/30/2026): $9.92Market Cap: $366.9 MilSector: FinancialsIndustry: Multi-Sector Holdings
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Low stock price volatilityVol 12M is 6.0% | Trading close to highsDist 52W High is -2.2%, Dist 3Y High is -2.2% Weak multi-year price returns2Y Excs Rtn is -43%, 3Y Excs Rtn is -82% |
| Low stock price volatilityVol 12M is 6.0% |
| Trading close to highsDist 52W High is -2.2%, Dist 3Y High is -2.2% |
| Weak multi-year price returns2Y Excs Rtn is -43%, 3Y Excs Rtn is -82% |
Qualitative Assessment
AI Analysis | Feedback
Mountain Lake Acquisition II (MLAA) stock has remained largely at the same level since it went public on 3/19/2026 because of the following key factors:
1. Mountain Lake Acquisition II's (MLAA) stock has remained largely at its IPO price level due to its structure as a Special Purpose Acquisition Company (SPAC), where the initial public offering proceeds are held in a trust account. This trust mechanism provides a redemption floor, typically around the $10.00 per share IPO price, as investors have the option to redeem their shares for this amount if a business combination is not completed or approved. MLAA's IPO in January 2026 raised $360 million at $10.00 per unit, with shares beginning separate trading on March 19, 2026. A significant portion of the IPO proceeds, such as over $36 million worth of shares as of March 31, 2026, could be redeemed, reinforcing the price floor.
2. The inability to secure a definitive business combination agreement has prevented significant stock movement beyond the trust value. MLAA initially entered into a non-binding Letter of Intent (LOI) with Terra Quantum AG on April 9, 2026, for a proposed business combination valued at $3.25 billion. However, the exclusivity period for this LOI expired in April 2026, and on May 28, 2026, Terra Quantum AG announced a definitive business combination agreement with a different SPAC, Axiom Intelligence Acquisition Corp 1 (AXINU), for an equity value of $3.5 billion, effectively terminating MLAA's potential deal with Terra Quantum. Without a secured merger target, the stock lacks the specific catalyst typically needed for appreciation beyond its cash-in-trust value.
Show more
Stock Movement Drivers
Fundamental Drivers
nullnull
Market Drivers
1/31/2026 to 5/29/2026| Return | Correlation | |
|---|---|---|
| MLAA | ||
| Market (SPY) | 9.6% | 17.5% |
| Sector (XLF) | -3.0% | 18.3% |
Fundamental Drivers
nullnull
Market Drivers
10/31/2025 to 5/29/2026| Return | Correlation | |
|---|---|---|
| MLAA | ||
| Market (SPY) | 11.5% | 17.5% |
| Sector (XLF) | -0.7% | 18.3% |
Fundamental Drivers
nullnull
Market Drivers
4/30/2025 to 5/29/2026| Return | Correlation | |
|---|---|---|
| MLAA | ||
| Market (SPY) | 38.0% | 17.5% |
| Sector (XLF) | 7.4% | 18.3% |
Fundamental Drivers
nullnull
Market Drivers
4/30/2023 to 5/29/2026| Return | Correlation | |
|---|---|---|
| MLAA | ||
| Market (SPY) | 89.0% | 17.5% |
| Sector (XLF) | 63.2% | 18.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MLAA Return | - | - | - | - | - | 1% | 1% |
| Peers Return | 0% | 0% | |||||
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 101% |
Monthly Win Rates [3] | |||||||
| MLAA Win Rate | - | - | - | - | - | 33% | |
| Peers Win Rate | 33% | ||||||
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| MLAA Max Drawdown | - | - | - | - | - | - | |
| Peers Max Drawdown | |||||||
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AACP, ACAA, ACGC, AMAN, ARCI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/29/2026 (YTD)
How Low Can It Go
MLAA has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -15.5% | -18.8% |
| % Gain to Breakeven | 18.4% | 23.1% |
| Time to Breakeven | 80 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -10.7% | -9.5% |
| % Gain to Breakeven | 12.0% | 10.5% |
| Time to Breakeven | 26 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -16.1% | -6.7% |
| % Gain to Breakeven | 19.1% | 7.1% |
| Time to Breakeven | 270 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -19.7% | -19.2% |
| % Gain to Breakeven | 24.5% | 23.8% |
| Time to Breakeven | 123 days | 105 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
MLAA has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -21.4% | -12.2% |
| % Gain to Breakeven | 27.3% | 13.9% |
| Time to Breakeven | 272 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -26.1% | -17.9% |
| % Gain to Breakeven | 35.3% | 21.8% |
| Time to Breakeven | 162 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -78.3% | -53.4% |
| % Gain to Breakeven | 359.8% | 114.4% |
| Time to Breakeven | 2329 days | 1085 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Trade Ideas
Select ideas related to MLAA.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04302026 | EEFT | Euronet Worldwide | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 04242026 | HOMB | Home BancShares | Insider | Insider Buys | Low D/EStrong Insider BuyingCompanies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap | 1.5% | 1.5% | 0.0% |
| 03312026 | HBAN | Huntington Bancshares | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 7.1% | 7.1% | 0.0% |
| 03312026 | NP | Neptune Insurance | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 3.9% | 3.9% | 0.0% |
| 03272026 | JKHY | Jack Henry & Associates | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 0.3% | 0.3% | -4.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 9.96 |
| Mkt Cap | 0.4 |
| Rev LTM | - |
| Op Inc LTM | - |
| FCF LTM | - |
| FCF 3Y Avg | - |
| CFO LTM | - |
| CFO 3Y Avg | - |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | - |
| Rev Chg 3Y Avg | - |
| Rev Chg Q | - |
| QoQ Delta Rev Chg LTM | - |
| Op Inc Chg LTM | - |
| Op Inc Chg 3Y Avg | - |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | - |
| CFO/Rev 3Y Avg | - |
| FCF/Rev LTM | - |
| FCF/Rev 3Y Avg | - |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.4 |
| P/S | - |
| P/Op Inc | - |
| P/EBIT | - |
| P/E | - |
| P/CFO | - |
| Total Yield | - |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | - |
| D/E | 0.0 |
| Net D/E | -0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 0.2% |
| 3M Rtn | 0.3% |
| 6M Rtn | 0.3% |
| 12M Rtn | 0.3% |
| 3Y Rtn | 0.3% |
| 1M Excs Rtn | -6.0% |
| 3M Excs Rtn | -9.9% |
| 6M Excs Rtn | -11.7% |
| 12M Excs Rtn | -28.4% |
| 3Y Excs Rtn | -82.5% |
FDA Approved Drugs Data
Expand for More| Post-Approval Fwd Returns | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FDA App # | Brand Name | Generic Name | Dosage Form | FDA Approval | 3M Rtn | 6M Rtn | 1Y Rtn | 2Y Rtn | Total Rtn |
| ANDA040486 | METAXALONE | metaxalone | tablet | 2272015 | |||||
| ANDA091159 | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | tablet | 3122014 | |||||
| ANDA204371 | GRISEOFULVIN, ULTRAMICROSIZE | griseofulvin, ultramicrosize | tablet | 1092014 | |||||
Earnings Returns History
Updated 5/29/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
Insider Activity
Updated 4/26/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Grinberg, Paul | Chief Executive Officer | Through Mountain Lake Acquisition Sponsor II LLC | Buy | 1302026 | 10.00 | 510,000 | 5,100,000 | 5,100,000 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.